Contact
Please use this form to send email to PR contact of this press release:
NuCana Announces First Patients Dosed in Phase I Study of NUC-7738
TO:
Please use this form to send email to PR contact of this press release:
NuCana Announces First Patients Dosed in Phase I Study of NUC-7738
TO: